Kontafarma China Holdings Ltd (HK:1312) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kontafarma China Holdings Limited has announced that its Board of Directors will convene on August 28, 2024, to review and approve the subsidiary’s interim financial results for the first half of the year and to discuss the potential distribution of an interim dividend. The upcoming board meeting is set to shape the company’s financial strategies moving forward. This announcement was made by Chairman Wang Feifei on behalf of the company.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.